Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
Clinical trial NCT01274624 · COMPLETED
Trial details
- NCT number
- NCT01274624
- Sponsor
- Oncolytics Biotech
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2018-02-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.